Trial Profile
Pharmacokinetics and Tolerability of Peginf-Sa in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Nov 2015
Price :
$35
*
At a glance
- Drugs Peginterferon SA (Primary) ; Peginterferon alfa-2a
- Indications Hepatitis B; Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 25 Mar 2013 New trial record
- 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.